SABCS 2021 Conference Coverage on VuMedi

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

SABCS 2021 Conference Coverage on VuMedi

Videos

Playback speed

10 seconds

Update on T-DXd vs. T-DM1 in HER2+ MBC: Subgroup Analyses From the Phase 3 DESTINY-Breast03 Study

By SABCS 2021 Conference Coverage on VuMedi FEATURING Sara A. Hurvitz

0 views

December 22, 2021

This video was recorded prior to the FDA granting regular approval to Trastuzumab Deruxtecan in ...
read more ↘ the 2L setting for Select HER2+ mBC
↖ read less

Comments 0

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Videos